These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25485012)

  • 1. Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment survey.
    Violette PD; Kamel-Reid S; Graham GE; Reaume MN; Jewett MA; Care M; Basiuk J; Pautler SE
    Can Urol Assoc J; 2014 Nov; 8(11-12):E832-40. PubMed ID: 25485012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Needs Assessment Survey for the Management of Kidney Cancer.
    Lavallée LT; Fitzpatrick R; Cnossen S; Witiuk K; Wood L; Basiuk J; Vanhuyse M; Tanguay S; Pautler SE; Finelli A; Jewett MA; Cagiannos I; Morash C; Breau RH
    Urol Pract; 2017 May; 4(3):257-263. PubMed ID: 37592641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists.
    Boycott K; Hartley T; Adam S; Bernier F; Chong K; Fernandez BA; Friedman JM; Geraghty MT; Hume S; Knoppers BM; Laberge AM; Majewski J; Mendoza-Londono R; Meyn MS; Michaud JL; Nelson TN; Richer J; Sadikovic B; Skidmore DL; Stockley T; Taylor S; van Karnebeek C; Zawati MH; Lauzon J; Armour CM;
    J Med Genet; 2015 Jul; 52(7):431-7. PubMed ID: 25951830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine.
    Bonter K; Desjardins C; Currier N; Pun J; Ashbury FD
    BMJ Open; 2011 Jul; 1(1):e000110. PubMed ID: 22021765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician attitudes about genetic testing for localized prostate cancer: A national survey of radiation oncologists and urologists.
    Kim SP; Meropol NJ; Gross CP; Tilburt JC; Konety B; Yu JB; Abouassaly R; Weight CJ; Williams SB; Shah ND
    Urol Oncol; 2018 Nov; 36(11):501.e15-501.e21. PubMed ID: 30190177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada.
    Selvarajah S; Schrader KA; Kolinsky MP; Rendon RA; El Hallani S; Fleshner NE; Hotte SJ; Lorentz J; Panabaker K; Perrier R; Pouliot F; Spatz A; Yip S; Chi KN
    Can Urol Assoc J; 2022 Oct; 16(10):321-332. PubMed ID: 36240332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada.
    Spence T; Sukhai MA; Kamel-Reid S; Stockley TL
    Curr Oncol; 2019 Dec; 26(6):353-360. PubMed ID: 31896933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Patients with Cardiovascular Implantable Electronic Devices Undergoing Radiation Therapy: A National Survey of Canadian Multidisciplinary Radiation Oncology Professionals.
    Safavi AH; Louie AV; Elzibak AH; Warner A; Donovan EK; Detsky JS
    Adv Radiat Oncol; 2023; 8(4):101184. PubMed ID: 36874173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada.
    Armour CM; Dougan SD; Brock JA; Chari R; Chodirker BN; DeBie I; Evans JA; Gibson WT; Kolomietz E; Nelson TN; Tihy F; Thomas MA; Stavropoulos DJ;
    J Med Genet; 2018 Apr; 55(4):215-221. PubMed ID: 29496978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of medical knowledge toward genetic testing for individuals with hereditary breast and ovarian cancer syndrome in Brazil.
    Lasta JL; Groto AD; Brandalize APC
    Prev Med Rep; 2023 Oct; 35():102356. PubMed ID: 37649554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Workforce Implications of Increased Referrals to Hereditary Cancer Services in Canada: A Scenario-Based Analysis.
    Dragojlovic N; Borle K; Kopac N; Nisselle A; Nuk J; Jevon M; Friedman JM; Elliott AM; Lynd LD
    Curr Oncol; 2023 Jul; 30(8):7241-7251. PubMed ID: 37623006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Referral Patterns and Responses to Clinical Scenarios: A Survey of Primary Care Providers and Clinical Geneticists.
    Truong TK; Kenneson A; Rosen AR; Singh RH
    J Prim Care Community Health; 2021; 12():21501327211046734. PubMed ID: 34583568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
    Hampel H; Bennett RL; Buchanan A; Pearlman R; Wiesner GL;
    Genet Med; 2015 Jan; 17(1):70-87. PubMed ID: 25394175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.